Webb William Trenton 4

What Happened
William T. Webb, American Group President of Surgery Partners (SGRY), was granted 31,892 restricted stock awards (RSAs) on March 5, 2026 (20,454 and 11,438 shares) at $14.11 per share, worth a combined $449,996. Separate transactions show Webb sold 1,794 shares on March 5 at $13.86 ($24,865) and 272 shares on March 6 at $13.93 ($3,789); per the filing those sales were to satisfy tax withholding obligations related to prior RSA vestings.

Key Details

• Grants (code A): 20,454 RSAs @ $14.11 = $288,606 (vests on 1st anniversary); 11,438 RSAs @ $14.11 = $161,390 (vests on 2nd anniversary). Grant date: 2026-03-05.
• Sales (code S): 1,794 shares @ $13.86 on 2026-03-05 ($24,865); 272 shares @ $13.93 on 2026-03-06 ($3,789). Footnotes state these sales were to satisfy tax withholding for vestings on Feb 28 and Mar 2, 2026.
• Filing: Report filed 2026-03-09 for transactions dated Mar 5–6, 2026 — appears timely (within the SEC’s two business day Form 4 window).
• Weighted-average price note: the reported prices are weighted averages; the filer offers to provide per-share sale price details on request.
• Shares owned after transaction: not disclosed in the provided excerpt of the filing.

Context

• These were awards (RSAs), not open-market purchases; RSAs vest over time (1- and 2-year anniversaries), so the grants are long-term compensation, not an immediate market buy.
• The small sales were tax-withholding related (routine) and do not necessarily indicate personal selling for investment reasons.
• Purchases/acquisitions (awards) are generally more informative for bullish signals than routine tax-related sales; remain factual and watch future Form 4s for any additional sales or exercise activity.